COVID vaccines deployed in US highly effective at reducing h

Researchers in the United States have conducted a large-scale study showing that the two-dose regimen vaccines developed by Pfizer-BioNTech and Moderna to protect against coronavirus disease 2019 (COVID-19) appear to be highly effective and durable in reducing the risk of hospitalizations and deaths following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Related Keywords

North Carolina , United States , China , State Of North Carolina , North Carolina State University , Wuhan , Hubei , Sally Robertson , Danyu Lin , Pfizer , Human Services , Drug Administration , Carolina Department Of Health , Carolina State University , Chapel Hill Gillings School , Global Public Health , North Carolina Department , United States Over , Surveillance Data , Image Credit , Coronavirus , Coronavirus Disease Covid 19 , Efficacy , Health And Human Services , Immunity , Immunization , Public Health , Research , Espiratory , Cars , Ars Cov 2 , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Yndrome , Vaccine , Virus ,